A pan-cancer screen identifies drug combination benefit in cancer cell lines at the individual and population level
泛癌筛选可在个体和群体水平上识别癌细胞系中的药物组合获益。
期刊:Cell Reports Medicine
影响因子:10.6
doi:10.1016/j.xcrm.2024.101687
Vis, Daniel J; Jaaks, Patricia; Aben, Nanne; Coker, Elizabeth A; Barthorpe, Syd; Beck, Alexandra; Hall, Caitlin; Hall, James; Lightfoot, Howard; Lleshi, Ermira; Mironenko, Tatiana; Richardson, Laura; Tolley, Charlotte; Garnett, Mathew J; Wessels, Lodewyk F A